We are currently enrolling patients in a clinical research study for an investigational medication who have advanced Liposarcoma or Leiomyosarcoma and have been treated with an anthracycline and at least 1 additional cytotoxic chemotherapy regimen.
You may be eligible to participate in the study if you:
Additional criteria will be assessed by the study doctor to confirm your eligibility for this study.
Qualified participants will receive:
Additional information about this study may also be found at www.clinicaltrials.gov.
© Acurian, Inc. 2012
This website is published by Acurian, Inc. which is solely responsible for its content.
This website is only intended for residents of the United States of America
Last updated: February 22, 2012
You may click the OK button to access the requested website or click Cancel to remain on current page.